Oncology
Cancer clinical trials
Studies of cancers and tumors of every type and site, from prevention to treatment. We’re tracking 20,209 recruiting studies in this area right now.
By phase
- Not applicable9,535
- Phase 24,407
- Phase 12,674
- Phase 1/Phase 21,653
- Phase 31,394
- Phase 2/Phase 3285
- Phase 4261
Top conditions
- Breast Cancer1,201
- Prostate Cancer645
- Cancer634
- Colorectal Cancer480
- Lung Cancer418
- Ovarian Cancer338
- Multiple Myeloma329
- Pancreatic Cancer290
- Gastric Cancer283
- Acute Myeloid Leukemia280
- Hepatocellular Carcinoma256
- Solid Tumor247
- Advanced Solid Tumor233
- Head and Neck Cancer226
- Cervical Cancer225
- Endometrial Cancer210
- Advanced Solid Tumors203
- Esophageal Cancer190
Leading sponsors
- M.D. Anderson Cancer Center453
- Fudan University302
- National Cancer Institute (NCI)293
- Memorial Sloan Kettering Cancer Center291
- Sun Yat-sen University274
- Mayo Clinic238
- City of Hope Medical Center145
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences142
- AstraZeneca133
- Second Affiliated Hospital, Zhejiang University, School of Medicine128
Where studies are running
- California1,414
- Texas635
- Arizona507
- Florida436
- Alabama430
- New York406
- Massachusetts340
- Maryland329
- New Jersey272
- Pennsylvania233
Recruiting studies20,209 total
- NCT06468332Recruiting
AI learning from MRI and tissue to improve prostate cancer care
This study uses artificial intelligence to look at your MRI scans, tissue samples, and medical records to learn more about prostate cancer and find better ways to treat it. You may join if you've had prostate removal surgery or have advanced prostate cancer.
NovaraAges 18–80 - NCT06802666RecruitingPhase 2
Short radiation plus combo drugs for rectal cancer
This trial tests a new combination for rectal cancer that hasn't spread far: a short course of radiation followed by two drugs (AK112 and CAPOX). The goal is to shrink the tumor before surgery and possibly avoid more aggressive treatments.
HubeiAges 18–75 - NCT06796751Recruiting
Better DNA testing for unclear genetic results
This study uses a new, advanced DNA sequencing method (long-read sequencing) to try to clarify unclear or incomplete genetic test results. If you or a family member have had genetic testing that left unanswered questions, this trial may help find more definite answers.
Bologna, BolognaAges 4 weeks+ - NCT06802718RecruitingPhase 3
Interferon-alpha after Chemo for Favorable-Risk AML
This study tests if a medicine called interferon-alpha can help keep leukemia from coming back after initial treatment. It is for people with a favorable-risk type of AML who still have tiny traces of leukemia-related genetic material after finishing their first round of chemo.
Beijing, Beijing MunicipalityAges 18–70 - NCT06803251Recruiting
Vascular surgeon role in removing abdominal or pelvic masses
This study looks at how a vascular surgeon (a blood vessel specialist) can help when removing masses in the back of the abdomen or pelvis. If you have a mass that touches blood vessels and you need surgery, this trial may be a good fit for you.
Bologna, ItaliaAges 18 years+ - NCT06185777Recruiting
Exercise therapy program for cancer patients in treatment
This study is testing a care program that helps cancer patients add exercise to their treatment. If you're currently on chemo, immunotherapy, or radiation and have side effects like fatigue (or just want guidance on exercise), you may be able to join.
Freiburg im Breisgau, Baden-WurttembergAges 18 years+ - NCT06489795Recruiting
Laparoscopic surgery for early cervical cancer
This trial studies how well a less invasive laparoscopic surgery works for women with early-stage cervical cancer. If you have a small tumor and need a hysterectomy, this may be an option for you.
Ludwigsburg, Baden-WurttembergAges 18 years+ - NCT06805812Recruiting
Predicting outcomes of CDK4/6 inhibitors plus hormone therapy for advanced breast cancer
This study looks at how well a type of targeted therapy (called CDK4/6 inhibitors) combined with hormone therapy works as the first treatment for advanced breast cancer that is hormone receptor-positive and HER2-negative. Researchers want to find patterns that could help predict which patients benefit most.
AvianoAges 18 years+ - NCT06805045Recruiting
Image-guided surgery for rectal cancer
This trial uses special imaging to guide surgery for rectal cancer. It studies whether detailed scans taken before surgery can help doctors remove the cancer more precisely.
BolognaAges 18–80 - NCT06805669Recruiting
Early palliative care for advanced soft tissue sarcoma
This study tests whether adding palliative care early on to standard cancer treatment improves quality of life for people newly diagnosed with advanced or metastatic soft tissue sarcoma.
Toronto, OntarioAges 18 years+ - NCT06805552Recruiting
Sarcopenia and targeted therapy in liver cancer
This study looks at muscle loss in people with liver cancer who are receiving targeted therapy (TKIs). It aims to understand how muscle health affects treatment outcomes. You may qualify if you have intermediate or advanced liver cancer or earlier stage that hasn't responded to prior treatments.
BolognaAges 18 years+ - NCT06346041RecruitingEarly Phase 1
Testing a new IV drug IDOV-SAFE for advanced solid tumors
This trial tests a new intravenous drug called IDOV-SAFE in people with advanced solid tumors that have stopped responding to standard treatments or have no effective standard option. The goal is to see if it is safe and effective.
BeijingAges 18–75 - NCT06106529RecruitingPhase 3
Reducing hot flashes in women on hormone therapy for breast cancer
This trial tests a new approach to reduce hot flashes in women taking hormone therapy for breast cancer. You may be able to join if you have at least 14 hot flashes a week and are not taking certain other treatments.
Delft, South HollandAges 18 years+ - NCT06427447RecruitingPhase 3
Chemo with or without radiation after pancreatic cancer surgery
This trial compares adding radiation to chemotherapy versus chemotherapy alone after surgery for pancreatic cancer. It is for people whose cancer had certain high-risk features found during surgery, and who have not yet started additional treatment.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06276686RecruitingEarly Phase 1
Exercise With Chemoradiotherapy for Locally Advanced Rectal Cancer
This study tests whether adding regular exercise during your standard chemoradiotherapy can help the treatment work better for people with locally advanced rectal cancer. It is designed for patients who have already been offered this type of therapy before surgery.
Cottingham, East YorkshireAges 18 years+ - NCT06668792RecruitingPhase 2
Study of BCD-248 for returning multiple myeloma
This trial tests a new treatment called BCD-248 for people whose multiple myeloma has come back or stopped responding to at least two prior treatments. It aims to see if it is safe and effective.
KaliningradAges 18 years+ - NCT06806488Recruiting
Marginal zone lymphoma patient study
This study looks at patients with marginal zone lymphoma who were diagnosed and treated at a specific hospital in Italy between 2012 and 2018. It aims to learn more about how the disease progresses and how patients respond to treatment.
Bologna, BolognaAges 18 years+ - NCT07441785Recruiting
Comparing stomach reconstruction types after upper stomach cancer surgery
This study compares different ways to rebuild the digestive tract after removing the upper part of the stomach for cancer. It aims to find which method works best for eating and quality of life.
MoscowAges 18 years+ - NCT07435623Recruiting
Long-term side effects of radiation for cervical and endometrial cancers
This study looks at late side effects in patients who had radiation therapy after surgery for cervical or endometrial cancer. Understanding these effects can help improve future care.
Mumbai, MaharashtraAges 18–75 - NCT06785441Recruiting
Decision aid for older men considering active surveillance for prostate cancer
This study tests a decision aid to help men aged 65 and older with early-stage prostate cancer decide whether to choose active surveillance (monitoring the cancer instead of immediate treatment). The goal is to see if the tool helps men and their care partners make a more informed choice.
Houston, TexasAges 65 years+ - NCT07444437RecruitingPhase 2
LM103 after surgery for lung cancer
This trial tests if LM103, given after surgery and standard chemotherapy, helps prevent non-small cell lung cancer from coming back. It is for people who have already had chemotherapy or immunotherapy before surgery and whose cancer did not return after surgery.
Guangzhou, GuangdongAges 18–75 - NCT07439653RecruitingPhase 1/Phase 2
Testing TORL-5-700 for advanced lymphoma
This trial tests a new treatment called TORL-5-700 for people with certain types of non-Hodgkin lymphoma that have not responded to other treatments. The goal is to see how safe it is and how well it works.
Fullerton, CaliforniaAges 18 years+ - NCT07438782RecruitingPhase 1
Investigational drug for advanced solid tumors
This study tests an investigational drug, GSK5533524, either alone or with other treatments, in adults with advanced solid tumors that have stopped responding to standard therapies. The goal is to find a safe dose and see if it helps shrink or control the tumor.
Philadelphia, PennsylvaniaAges 18 years+ - NCT07441460RecruitingPhase 3
KN026 plus HB1801 after surgery for HER2-positive breast cancer
This trial tests a combination of two drugs (KN026 and HB1801) given after surgery to prevent breast cancer from coming back in people with HER2-positive breast cancer that had spread to lymph nodes. It aims to improve cure rates with a targeted approach.
Shanghai, Shanghai MunicipalityAges 18 years+
Common questions
- How many cancer clinical trials are recruiting?
- Clin2 is tracking 20,209 recruiting oncology studies from the U.S. registry right now, out of 30,299 we cover in this area in total.
- What does “Cancer” cover here?
- Studies of cancers and tumors of every type and site, from prevention to treatment. We group each study into cancer based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a cancer trial near me?
- Use the search to filter cancer studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Kidney & urinary
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.